Application: injectable

Dosage: 100mg/ml

Package: 1

Package Type: ampule


Testovis (Testosterone Propionate) by SIT is the shortest commonly ester attached to the Testosterone hormone. This means it takes your body the least amount of time to rid itself of the ester and release the parent hormone into the body. Testosterone is the primary male sex hormone. It is the responsible for producing mainly male-specific sexual traits. When synthesized, it is usually attached to an ester to delay its release into the body. Due to its short active life, Testovis typically needs to be injected every other day at a minimum. Anecdotally, Testovis SIT causes the least side effects and the least bloating; these side effects usually subside very quickly when use is ceased.

Testovis 100mg Dosage

Most athletes generally take Testovis between 100 mg every other day and the consensus for dosage usually keeps it around 350 mg each week. For testosterone replacement therapy people generally take between 25 to 50 mg 2 to 3 times per week. In extreme cases athletes will take Testovis up to 200 mg per day but this can increase the risk of estrogen-based side effects so it’s very important to consider controlling these side effects with anti-estrogens are estrogen blockers. Most men generally won’t need this much Testovis for performance enhancement but depending on the size of the athletes sometimes 200 mg each day are required to maintain proper blood levels. This definitely isn’t the amount that you want to try for your very first cycle but it is important to note that many athletes have had success on doses this high.

Testovis SIT Side Effects

Although the side effects of Testovis are similar to the ones of Enanthate and Cypionate these, as already mentioned, occur less fre-quently. However, if there is a predisposition and very high dosages are taken, the known androgenic-linked side effects such as acne vulgaris, accelerated hair loss, and increased growth of body hair and deep voice can occur. An increased libido is common both in men and women with the use of Testovis. Despite the high conversion rate of propionate into estrogen gynecomastia is less common than with other testosterones. The same is true for possible water reten-tion since the retention of electrolytes and water is less pronounced. The administration of testosterone-stimulating compounds such as HCG and Clomid can, however, also be advised with propionate use since it has a strong influence on the hypothalamohypophysial tes-ticular axis, suppressing the endogenous hormone production. The toxic influence on the liver is minimal so that a liver damage is unlikely. What athletes dislike most about Testovis are the frequent injections that are necessary.